Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.3K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

652
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
652
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

668
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
668
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

521
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
521
Diabetic Nephropathy01:28

Diabetic Nephropathy

2
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of hemoglobin increase in patients with acute kidney injury and severe anemia on major adverse kidney events.

Renal failure·2026
Same author

Kidney health without borders: a multilingual kidney education platform.

Kidney international·2026
Same author

Development of a nomogram for predicting kidney replacement therapy and hyperkalemia in acute kidney injury.

Nefrologia·2026
Same author

Life-Cycle Assessment of an Industrial Recycling Process for Photovoltaic Panels Integrating Mechanical and Air-Assisted Pyrolysis Treatments.

Energy & fuels : an American Chemical Society journal·2026
Same author

Effect of Intravenous Iron Dextran on Kidney Outcomes in Acute Kidney Injury with Iron Deficiency: A Randomized Trial.

Kidney360·2026
Same author

Integrating Lean Six Sigma and Life-Cycle Assessment approaches for sustainable manufacturing of fertilizers.

Integrated environmental assessment and management·2026
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
Same journal

The "Hear My Last Wish" Initiative: Leveraging Voiceprint Technology to Bridge the Gap Between Donor Intent and Family Consent in Taiwan.

Kidney international·2026
Same journal

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

2.0K

CKD in disadvantaged populations.

Guillermo Garcia-Garcia1, Vivekanand Jha2,

  • 1Nephrology Service, Hospital Civil de Guadalajara, University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico.

Kidney International
|January 31, 2015
PubMed
Summary
This summary is machine-generated.

Chronic kidney disease (CKD) disproportionately affects disadvantaged groups due to socioeconomic factors and limited healthcare access. Addressing this requires accessible dialysis, cost-effective prevention, and promoting kidney transplantation to reduce health disparities.

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

2.0K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

Area of Science:

  • Nephrology
  • Public Health
  • Health Disparities

Background:

  • Chronic kidney disease (CKD) presents a significant global health burden, disproportionately affecting socioeconomically disadvantaged populations.
  • Health disparities in CKD are driven by a combination of global factors, population-specific issues, low socioeconomic status, and inadequate access to healthcare.
  • Genetic or biological predispositions are exacerbated by socioeconomic factors, leading to poorer renal health outcomes in vulnerable communities.

Discussion:

  • Effective management of CKD in disadvantaged populations necessitates a dual strategy: expanding dialysis accessibility through low-cost, remote-practice alternatives and implementing/evaluating cost-effective prevention programs.
  • Promoting kidney transplantation is crucial, involving the expansion of deceased-donor programs and the utilization of affordable, generic immunosuppressive medications.
  • A comprehensive approach, including community outreach, education, economic improvement, and preventive medicine access for high-risk individuals, is essential to combat end-stage renal disease (ESRD) and its link to disadvantage.

Key Insights:

  • Socioeconomic status and healthcare access are critical determinants of CKD burden and progression.
  • Innovative and affordable renal care solutions are needed for remote and underserved populations.
  • Integrated public health strategies addressing socioeconomic determinants are vital for CKD prevention and management.

Outlook:

  • Future efforts should focus on policy changes and community-level interventions to reduce health disparities in CKD.
  • Continued research into low-cost dialysis technologies and effective preventive strategies is paramount.
  • Achieving health equity in renal care requires a multi-faceted approach involving healthcare providers, policymakers, and community stakeholders.